A vaccinated child can still get chickenpox, though the odds are low and the illness is almost always far milder than what an unvaccinated child would experience. The medical term for this is “breakthrough varicella,” and it occurs because the vaccine, while highly effective, does not produce perfect lifelong immunity in every recipient. A meta-analysis pooling data from multiple studies found that children who received one dose of the varicella vaccine developed breakthrough chickenpox at a rate of about 8.5 cases per 1,000 person-years, while those who received two doses saw that drop to roughly 2.2 cases per 1,000 person-years.1PubMed. Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: Results from a meta-analysis The picture gets more interesting when you look at why some vaccinated children get sick and others don’t, how quickly protection wanes, and what a breakthrough case actually looks and feels like compared to the real thing.
How Common Breakthrough Chickenpox Actually Is
The word “breakthrough” makes it sound dramatic, but the numbers are reassuring. In a large Chinese surveillance study covering hundreds of thousands of vaccinated individuals, the overall breakthrough rate was about 0.25%. Among those who had received just one dose, it was 0.39%; among two-dose recipients, it dropped to 0.10%.2PubMed Central. Analysis on the Epidemiological Characteristics of Breakthrough Varicella Cases and Incremental Effectiveness of 2-Dose Varicella Vaccine in China A matched case-control study in Qingdao found that two doses of the vaccine were about 82% effective at preventing chickenpox, compared with roughly 45% for a single dose.3PubMed Central. Effectiveness of one-dose versus two-dose varicella vaccine in children in Qingdao, China: a matched case-control study The gap between one dose and two is consistent across studies and is the main reason most countries that include varicella in their immunization schedules now recommend two doses.
Still, “uncommon” and “impossible” are different things. In settings where children are in close contact every day, like classrooms and daycare centers, even a small breakthrough rate can produce noticeable clusters. The key insight is that vaccination shifts the odds heavily in a child’s favor without eliminating risk entirely.
Why Protection Fades Over Time
The single biggest predictor of breakthrough chickenpox is how long ago the child was vaccinated. A large study tracking over 11,000 varicella cases found that the rate of breakthrough disease climbed steeply with time: from about 1.6 cases per 1,000 person-years within the first year after vaccination, to 9.0 per 1,000 person-years at five years, and as high as 58 per 1,000 person-years by nine years out.4New England Journal of Medicine. Loss of vaccine-induced immunity to varicella over time Children aged 8 to 12 who had been vaccinated more than five years earlier were about 2.6 times more likely to develop moderate or severe breakthrough disease than those vaccinated more recently.4New England Journal of Medicine. Loss of vaccine-induced immunity to varicella over time
Antibody studies tell a similar story. A retrospective study of healthcare workers who had been fully immunized found that about half had lost detectable anti-varicella antibodies by nine years after vaccination.5PubMed Central. Long-term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study Losing measurable antibodies does not necessarily mean complete vulnerability, because the immune system also has memory cells that can mount a rapid response upon re-exposure. But the trend is clear: the protection the vaccine provides is not static. It gradually weakens, and a second dose helps shore things up by boosting both the antibody level and the durability of the immune response.
What Raises the Risk of a Breakthrough Case
Beyond time since vaccination, several other factors tip the scales. Household contact with an active chickenpox case is the strongest single risk factor identified in research. One study found that living with someone who had chickenpox raised the odds of a breakthrough infection nearly 20-fold, which makes intuitive sense: the virus is airborne and extremely contagious, and prolonged indoor exposure gives even a partially protected immune system more virus to contend with.6PubMed Central. Risk factors for breakthrough varicella in healthy children
Age at vaccination also plays a role, though the evidence is a bit mixed. The same study found that children vaccinated at 14 months or younger had roughly double the odds of breakthrough disease compared to those vaccinated later.6PubMed Central. Risk factors for breakthrough varicella in healthy children A study in Turkey, however, did not find a significant association with vaccination before 15 months, though it did confirm that vaccination five or more years earlier raised the risk about 3.7-fold.7PubMed. Varicella rates among unvaccinated and one-dose vaccinated healthy children in Izmir, Turkey A Beijing study added a few more risk factors to the list, including a history of direct contact with a case and, interestingly, having received the varicella vaccine at the same time as other vaccines in a combined visit.8PubMed. The epidemiology and risk factors for breakthrough varicella in Beijing Fengtai district Whether co-administration truly blunts the immune response or whether this finding reflects other confounders is still debated.
What Breakthrough Chickenpox Looks Like
If your vaccinated child does come down with chickenpox, you will probably notice that something is off but that it looks nothing like the horror stories your parents told. Breakthrough varicella typically produces fewer than 50 skin lesions, and many cases have fewer than a dozen. The spots are often flat or only slightly raised rather than the classic fluid-filled blisters of unvaccinated chickenpox. Fever, if it occurs at all, tends to be low-grade and short-lived. The whole episode often resolves in a few days rather than the week or more of misery that unvaccinated children typically endure.
That mildness, however, creates a diagnostic puzzle. Because the rash looks atypical, parents and even clinicians sometimes mistake it for insect bites, contact dermatitis, or another viral rash.9PubMed. Reliability of direct varicella zoster virus loop-mediated isothermal amplification method for rapid diagnosis of breakthrough varicella When lab confirmation is needed, a PCR test on a swab from a lesion or even a saliva sample can identify the varicella-zoster virus. One study of children with suspected breakthrough chickenpox found that direct fluorescent antibody testing of lesion material was about 94% sensitive, while saliva PCR came in at about 87%.10PubMed. Laboratory Diagnosis of Breakthrough Varicella in Children Blood PCR was less reliable, picking up the virus in only about 61% of confirmed cases. In practice, most mild breakthrough cases are diagnosed clinically without lab testing, but if there is uncertainty or if public health tracking matters, testing is available.
Can a Vaccinated Child Spread Chickenpox to Others
Yes, but less efficiently. A household contact study published in JAMA found that vaccinated children with chickenpox were, on average, half as contagious as unvaccinated cases. The key variable was the number of lesions. Vaccinated children with fewer than 50 spots were only about a third as contagious, but those who developed 50 or more lesions were essentially just as contagious as an unvaccinated child with full-blown chickenpox.11JAMA. Contagiousness of Varicella in Vaccinated Cases: A Household Contact Study
This matters practically. A vaccinated child with a handful of mild spots at school poses a lower transmission risk than an unvaccinated child covered in blisters. But a breakthrough case on the more severe end of the spectrum can still seed an outbreak, especially in a classroom full of children whose own vaccine-induced immunity may have waned. Schools and daycares generally still exclude children with active chickenpox lesions, vaccinated or not, until the spots have crusted over.
Outbreaks in Highly Vaccinated Schools
Some of the most instructive data on breakthrough chickenpox comes from outbreak investigations in schools where vaccination rates were high. In one well-studied outbreak at an elementary school with 97% vaccination coverage, 12% of vaccinated students in affected classrooms developed chickenpox, compared to 43% of the few unvaccinated students. Children vaccinated more than five years before the outbreak were nearly seven times as likely to get sick as those vaccinated within the prior five years.12PubMed. Chickenpox outbreak in a highly vaccinated school population
A similar pattern emerged in preschool and school outbreaks in China. At one preschool where 96% of children had received the vaccine, 10 out of 12 cases during an outbreak were breakthrough infections in vaccinated children. The index case was a vaccinated child who had received the vaccine four years earlier.13International Journal of Infectious Diseases. Outbreak of varicella in a highly vaccinated preschool population In a school outbreak in Beijing where 98.6% of students had at least one dose and 63% had two, twenty cases were identified, and 95% of them were breakthroughs. Two-dose recipients had slightly higher attack rates than one-dose recipients in this particular setting, though the numbers were small enough that the difference could easily be noise.14PubMed Central. Varicella outbreak in a highly-vaccinated school population in Beijing, China during the voluntary two-dose era
These outbreaks can alarm parents, but context matters. In all of these documented school outbreaks, the total number of cases remained small, the vast majority of breakthrough cases were mild, and the attack rates were far lower than what would be expected in an unvaccinated population, where chickenpox spreads to roughly 90% of susceptible contacts. The vaccine bends the curve; it does not flatten it completely.
What to Do After Your Vaccinated Child Is Exposed
If your vaccinated child has been exposed to chickenpox, there are a couple of options depending on the situation. For children who have only had one dose of the vaccine, getting the second dose quickly after exposure can act as post-exposure prophylaxis. A Cochrane review found that among children given the vaccine after contact with a chickenpox case, about 23% still developed some form of chickenpox, compared with 78% of those who received a placebo or no vaccine. Even when mild chickenpox occurred, the vaccine appeared to prevent moderate and severe illness.15Cochrane Database of Systematic Reviews. Vaccines for post‐exposure prophylaxis against varicella (chickenpox) in children and adults
Timing is critical. A meta-analysis of post-exposure vaccination found that when the vaccine was given within three days of contact, it prevented about 80% of cases. Beyond three days, effectiveness dropped to about 50%.16PubMed Central. Effectiveness of varicella vaccine as post-exposure prophylaxis: a meta-analysis One study found that when post-exposure vaccination happened within 36 hours and involved close contact, effectiveness for preventing any disease reached about 95%, and it was 100% effective at preventing moderate or severe illness.17PubMed. Postexposure effectiveness of varicella vaccine If your child is already up to date on both doses, there is no additional vaccination step. You simply watch for symptoms and contact your pediatrician if a rash appears.
Does Breakthrough Chickenpox Affect Shingles Risk Later
One of the lingering questions parents have is whether a child who gets breakthrough chickenpox is now at risk for shingles later in life. Shingles happens when the varicella-zoster virus, which stays dormant in nerve cells after the initial infection, reactivates years or decades later. The answer so far is encouraging for vaccinated children. A study of children under 10 found that those who had been vaccinated (and thus exposed to the weakened vaccine strain rather than wild-type virus) had a 4- to 12-fold lower risk of developing shingles compared to children who had caught natural chickenpox.18The Pediatric Infectious Disease Journal. The Incidence and Clinical Characteristics of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination
The broader population picture is messier. A semi-national retrospective study in one country found that the overall rate of herpes zoster diagnoses in children actually increased in the post-vaccination era compared to the pre-vaccination era.19PubMed Central. The Association between Varicella Vaccination and Herpes Zoster in Children: A Semi-National Retrospective Study That sounds alarming, but it likely reflects several confounding factors: better awareness and diagnosis of shingles in children, changes in the circulating virus landscape, and the fact that fewer children are getting wild-type chickenpox boosters that used to silently re-stimulate adult immunity. The individual vaccinated child still appears to be better off than a child who got natural chickenpox, even if the population-level statistics are more complex to interpret.
Telling the Vaccine Strain From the Wild Virus
When a recently vaccinated child develops a chickenpox-like rash, there is sometimes a question of whether the rash was caused by the weakened vaccine virus itself or by a wild-type infection that happened to coincide with vaccination. The vaccine uses a live but attenuated strain called Oka (or vOka), and in rare cases it can cause a mild rash within a couple of weeks of the shot. Distinguishing the two matters for public health tracking and sometimes for clinical decision-making.
Laboratories can tell the difference using molecular techniques. One approach targets specific single-letter changes in the viral DNA. A method based on four specific genetic markers in the virus’s genome reliably distinguished the vaccine strain from wild-type strains representing the virus’s four main global lineages.20PubMed Central. Differentiation between wild-type and vaccines strains of varicella zoster virus (VZV) based on four single nucleotide polymorphisms Another method uses a rapid amplification technique followed by enzyme digestion, producing clearly different patterns for the vaccine strain and wild-type strains. This approach was designed to work directly on swab samples without the time-consuming step of extracting and purifying viral DNA first.21PubMed Central. Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification An older but widely validated PCR-based method targets a region of the virus where the vaccine strain carries three enzyme-cutting sites compared to two in wild-type strains, making differentiation straightforward.22PubMed. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR
Parents will almost never need to request these tests. They are primarily tools for outbreak investigations and surveillance programs. But knowing they exist helps address a common worry: if your child develops a few spots a week or two after vaccination, your doctor can determine whether it is the vaccine doing its job or an unlucky coincidence with a wild infection.
The Economic Side of Breakthrough Cases
Even though breakthrough chickenpox is milder, it still costs families time and money. A study in China calculated the per-person economic burden of chickenpox by severity. Mild cases cost about $172 per episode, moderate-to-severe cases about $257, and those requiring hospitalization about $487. Children with a history of vaccination (one or two doses) had lower per-person costs than unvaccinated children, whose average burden was about $286.23PubMed Central. Investigation and analysis of influencing factors on the economic burden of varicella disease in Qingyang, China, 2024 Indirect costs, mainly parents missing work to care for a sick child, made up the larger share of the financial hit.
At the population level, the savings from widespread vaccination are substantial. A modeling study for Portugal estimated that universal two-dose varicella vaccination would reduce total chickenpox cases by roughly 79 to 85%, cut outpatient visits by a similar margin, and reduce chickenpox-related hospitalizations by about 69 to 71%. The economic savings from a societal perspective, including lost workdays and caregiving costs, were projected at tens of millions of euros over the modeled period.24PubMed Central. Estimating the Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Portugal Using a Dynamic Transmission Model So while individual breakthrough cases still carry a cost, the overall economic argument for vaccination remains overwhelming, even accounting for the fact that no vaccine prevents every single case.